Mild depression prior to treatment can impact a patient's quality of life after treatment for head and neck cancer.
Modern Management of Intracranial Complications of Otogenic Infections
Pediatric Otogenic Intracranial Abscesses. Isaacson B, Mirabal C, et al: Otolaryngol Head Neck Surg 2010; 142 (March) : [434] [435] [436] [437] Ninety percent of otogenic infections that cause intracranial abscesses are managed surgically.
Background: Acute mastoiditis is an infection that can spread laterally to become a neck abscess or medially to become an intracranial abscess. Can these patients be treated with IV antibiotics? Should a tympanostomy tube be placed? Or, is a mastoidectomy required? A recent paper reviews management in these patients. Objective: To review the intracranial complications and management of acute mastoiditis. Design: Retrospective case review. Participants: 40 pediatric patients with an intracranial complication of mastoiditis. Methods: Inpatient admissions were screened for ICD-9 codes that could be related to intracranial abscesses, such as acute mastoiditis, facial paralysis, meningitis, intracranial abscess, Gradenigos syndrome, and others. Exclusion criteria included age >18 years and medical records that were unavailable or likely to be inaccurate. Interventions: Tympanostomy tube, mastoidectomy, intravenous (IV) antibiotics, and incision and drainage. Results: Intracranial abscess formation was the most common intracranial complication (75%), followed by lateral sinus thrombosis (40%), meningitis (28%), and otic hydrocephalus (10%). In the group of patients who had only extracranial complications, the most common complication was subperiosteal abscess (60%). Among patients with an intracranial complication, the mean patient age was 6 years (range, 8 months to 14 years). Sixty percent of these patients were male, and either side was almost equally likely to be involved. The most common presenting symptoms in these patients was fever (67%), followed by otalgia (57%), then headache, otorrhea, and postauricular swelling all occurred in approximately one-third of patients. Less common, but potentially very concerning, symptoms at the time of presentation included nausea/vomiting, diplopia, seizures, and extremity weakness. For the 30 patients with intracranial abscess formation, 10% had multiple intracranial abscesses at the time of presentation. Three of these patients were treated conservatively with only IV antibiotics and tympanostomy tube placement. Incision and drainage was performed in 75% of abscesses, and a canal wall up mastoidectomy was performed in 15%. No canal wall down mastoidectomies were performed in this population. The mean hospitalization was 2 weeks, with no mortalities. Cultures demonstrated that the most common organism was Streptococcus pneumoniae, followed by group A strep, and Staphylococcus aureus. Conclusions: 90% of these abscesses were managed with either incision and drainage or mastoidectomy. There were no mortalities in this study, thus even when intracranial complications of otitis media occur, they can almost always be effectively managed. Reviewer's Comments: Although this study documents that intracranial complications of otitis media can be managed without a significant risk of mortality, the retrospective nature of this study does not tell us the most effective management strategy. I think it would be reasonable to perform a tympanostomy and give IV antibiotics in all of these patients. Incision and drainage and mastoidectomy would also likely allow these symptoms to resolve more quickly and have little risk of morbidity. (Reviewer-Benjamin T. Crane, MD). Electrocochleography is perceived to have limited usefulness in Ménière's diagnosis, but it continues to be used at least occasionally by more than 50% of respondents.
Electrocochleography --Who Uses It and Why
Background: Ménière's disease is often difficult to diagnosis because of the wide spectrum of symptoms and the fluctuating nature of these symptoms over time. One test that may aid in diagnosis, but remains controversial, is electrocochleography (ECoG). The clinical interpretation of this test has focused on the amplitude ratio of the summating potential (SP) and action potential (AP) to response to auditory stimuli. Objective: To survey clinical otologists to find the prevalence and indications of clinical ECoG. Design: 13-Item survey. Participants: 344 surveys were sent to members of the American Otological Society (AOS) and the American Neurotology Society (ANS). A large number of the membership of these 2 societies overlaps, but the authors were careful not to poll the same individual more than once. Methods: A 13-item survey was sent by mail and fax. Up to 3 surveys were sent in an attempt to give nonresponders a chance to participate. There is currently no consensus on factors that predict acoustic neuroma growth.
Background: Acoustic neuromas, which are more accurately described as vestibular schwannomas, will occur in approximately 1 in 1,000 people over the course of their lifetimes, with approximately 1 new tumor in every 50,000 people per year. Many of these patients who will be diagnosed with this type of tumor will learn of it after an MRI. Growth of these tumors has historically been difficult to predict, although many small tumors do not grow. Objective: To review the literature to see if a consensus on factors that predict acoustic neuroma growth can be found. Design: Meta-analysis. Participants: Papers published on acoustic neuroma growth since 1990.
Methods:
The authors reviewed the literature on acoustic neuroma growth by performing searches in several databases. Attempts were made to identify published sources, as well as manuscripts in press, research theses, and conference proceedings. Interventions: Serial MRI.
Results:
The percentage of tumors that were found to grow during conservative management was widely variable ranging from 18% to 73%. When studies reported a growth rate as mm/year, the average growth rate varied from 0.3 to 4.8, although individual rates as rapid as 19 mm/year were reported. In some studies, tumor regression was reported at an incidence as high as 22%. Although more than half the studies included some patients who were followed for <1 year, the mean follow-up was between 17 and 65 months. Some studies reported that the first year after diagnosis was representative of the tumor growth rate, but there were also reports of tumors that grew after an initial stable period of several years. Although several studies were reviewed for this paper, most studies on acoustic neuroma growth suffer from at least 1 serious weakness, such as retrospective design, selection bias, and poor follow-up.
Conclusions:
There are no reliable indicators to tell us which ANs will grow. From this review, the authors conclude that most tumors do not grow, and when growth does occur, it is unpredictable; therefore, there is no safe period when a tumor no longer needs to be monitored. Reviewer's Comments: Acoustic neuromas are now more commonly diagnosed, but fewer need to be removed. Although several groups have published guidelines on how frequently MRI scans should be ordered there is little consensus. Practicing otolaryngologists such as ourselves are left to decide on an individual bases when to order these scans and how to treat the minority of patients that show evidence of growth.
(Reviewer-Benjamin T. Crane, MD).
Steroids Improve Vestibular Function as Measured by Caloric Testing
Corticosteroids in the Treatment of Vestibular Neuritis: A Systematic Review and Meta-Analysis. Goudakos JK, Markou KD, et al: Otol Neurotol 2010; 31 (February): 183-189 In patients with vestibular neuritis, steroids improve vestibular function as measured by caloric testing, but have not been shown to have a significant effect on symptoms.
Background: Treatment of vestibular neuritis usually includes vestibular suppressants, such as promethazine, as well as steroids and antiviral medications. Many of these patients will have their symptoms improve independent of therapy, but there are a significant number of patients who continue to have significant persistent vestibular dysfunction and dizziness for an extended period. Objective: To compare the value of steroids versus placebo in the treatment of vestibular neuritis. Design: Meta-analysis. Participants: 159 patients will vestibular neuritis reported in 4 placebo controlled trials of steroids versus placebo. Methods: For inclusion, a study had to meet the following criteria; (1) it had to be a randomized, controlled trial that compared steroids with placebo;
(2) patients had to have started therapy within 5 days of symptom onset; and (3) patients needed to have had at least 1 month of follow-up after therapy. Studies that included patients who had a contraindication to steroid therapy (eg, pregnancy or diabetes) were excluded. The initial search identified 157 articles that were eventually narrowed down to 4 studies that met the inclusion criteria. Interventions: Oral prednisolone/methylprednisolone versus placebo. Results: 2 studies reported that steroids improved the long-term recovery of vestibular function, while the other 2 studies reported earlier recovery of function without improving the long-term prognosis. Only 1 of these studies provided data on clinical symptoms. This study did not show a significant effect of steroids at 1, 3, or 6 months. Three of the 4 studies provided enough relevant data to allow meta-analysis of caloric function. When the caloric function was examined in terms of complete recovery at 12 months, steroid treatment had a significant effect on improving the rate of recovery. When lateralization of the caloric test was examined, it was found that at 12 months, there was also a significant benefit of steroids over placebo. However, due to limited data prior to 12 months, it was not possible to perform a meta-analysis for earlier time periods. Conclusions: This meta-analysis demonstrates that steroids have a significant effect on improving caloric function and symmetry 1 year after the onset of symptoms. However, there does not seem to be a significant effect of steroids on symptomatic improvement. Reviewer's Comments: The advantage of meta-analysis is that it can allow more powerful conclusions than can be determined from individual papers. The power of this meta-analysis was limited because only 4 studies were included. The meta-analysis of clinical symptoms was not meaningful because only 1 study included enough data to permit analysis. Even though the study was not able to demonstrate an effect of steroid therapy on vestibular neuritis symptoms, most of us will probably continue to treat these patients with steroids based on the data that demonstrates significant improvement in caloric function. (Reviewer-Benjamin T. Crane, MD).
